Supplementary Figure and Table Legends
Supplementary Figure 1 . Box plots of SNAP25 expression in each of the 5 data sets. Three probesets were present for measuring SNAP25 expression, and plots are shown for each. Probeset 202508_s_at exclusively targets the 3' UTR region rather than the coding region of the SNAP25 gene, whereas the other two probesets contain probesets matching regions in the exons. Since detection of mRNA based on 3' UTR probesets becomes less accurate for genes that have alternative polyadenylation sites in different tissues, 62 and SNAP25 contains multiple alternative polyadenylation sites in brain different from those in other tissues, 63 the probeset 202508_s_at results may be less reflective of true SNAP25 mRNA expression levels. Supplementary Table 1 : P-Values and fold changes for the list of 24 genes downregulated in AD consistently across 5 data sets. Supplementary Table 4 : P-Values for SNAP25 gene expression probe levels in male versus female samples in GSE11882. Bold typeface indicates significant p-values; italicization indicates p-values trending towards significance. Supplementary Table 5 : Summary of the 5 gene expression data sets utilized to identify genes downregulated in AD consistently across multiple data sets. Supplementary Table 6 : DAVID pathway enrichment results for 24 genes. Supplementary Table 7 : Significant SNPs in the region of each of the 24 genes according to given thresholds: (a) distance < 1 Mb up and downstream, p < 1e-2, for whole cohort only and (b) distance < 200 kb up and downstream, p < 5e-4, for each patient subset. Supplementary Table 8 : Lists of genes significantly differentially expressed between AD and control in 4 out of 5 gene expression datasets. a) Downregulated genes b) Upregulated genes Supplementary Table 9 : Gender-stratified differential expression analysis. Supplementary Table 10 : Lists of genes targeted by the compounds of interest, based on literature and data mining: (a) NEUROD6-relevant compounds and (b) SNAP25-relevant compounds. Supplementary Table 11 : Differential expression analysis between genders, stratifying by disease status. Affymetrix*Human*Genome* U133A*Array GSM21204,*GSM21206,*GSM21207,* GSM21209,*GSM21211IGSM21213,* GSM21216,*GSM21218IGSM21222,* GSM21224,*GSM21226,*GSM21230I GSM21232 Compared*samples*with*top*9*NFT* scores*vs*bottom*9*NFT*scores Datasets   SCG3  RGS7  NME1  GSE1297  TPI1  GOT2  MAGED1  GSE15222  MRPS11  ENC1  SLC17A7  GSE36980  PGAM1  GNG3  ATP6V1E1  GSE44772  ATP5B  PTPRN2  SYP  SLC25A11  PPP1R11  ATP1A3  KPNA2  YWHAB  ATP6V1G2  NEDD8  BNIP3  C14orf2  AP3B2  SNAP25  CACNG3  C14orf132  NEUROD6 UQCRC1   MRPS11  GOT2  BNIP3  SYP  GSE1297  ATP5B  ATP6V1G2 SNAP25  ATP1A3  GSE15222  SLC25A11  PTPRN2  NEUROD6  GNG3  GSE36980  AP3B2  PPP1R11  MAGED1  C14orf2  GSE5281  C14orf132  YWHAB  SLC17A7  CACNG3  RGS7  CFL1  ATP6V1E1  UQCRC1  TPI1   ASNA1  SLC25A11 NDUFA10  GPI  SHANK2  SLC35B1  GSE1297  LMO4  GABRA2  LDOC1  TTC3  CDK5  SYP  GSE15222  YWHAB  ATP5C1  GOT2  MPV17  GPHN  FKBP1B  GSE44772  ATP6V1H  APEX1  ATP1A3  TUBG2  SNAP25  GNG3  GSE5281  TPI1  AP3B2  SRD5A1  IDS  ATP6V1G2 SST  C14orf132  ARHGEF9  GOT1  PPP1R11 NEUROD6 C14orf2  MRPS11  ARF3  LDHA  NMNAT2 MAGED1  PPP3CA  ATP5B  BNIP3  LZTS1  PEX11B  SLC17A7  CACNG3  GABBR1  RAB11A  PTPRN2  NGFRAP1 ATP6V1E1 UQCRC1  GLS  PFKM  YWHAZ  CADPS  CHN1  NDRG4  RGS7  DGKZ  UCHL1  AK5   FXYD7  DDX41  SLC25A11  C12orf10 SV2B  C14orf132  GSE15222  ATP5J2  MAGED1  WSB2  FABP3  NEUROD6 SDHB  GSE36980  LRFN3  TRAPPC5  CRMP1  ATP5B  SYNGR1  RGS7  GSE44772  TPI1  SYT5  PTPRN2  DCTN1  SYNGR3  YWHAB  GSE5281  HPCA  SYP  DPYSL4  GABRA1 SLC17A7  ATP5G1  SEMA4F  GNG3  GFRA2  PGBD5  ATP6V1E1 ATP6V1G2  MICAL2  POP4  POLR2E  STMN2  ATP1A3  ANXA6  NAPA  ACLY  RAP1GDS1 AP3D1  C14orf2  CHRM1  GOT2  UQCRC1  BNIP3  MAPK9  PSMD8  PPP2R2C  ATP6V0D1  ELAVL4  PPP1R11  RAB15  EEF1A2  STS  ZFP64  COPS8  MKKS  ATP6V0C BCL11A  SRM  MRPL37  ATP6V1F  NPTXR  MRPS18A MRPS11  BSCL2  HK1  GBA  GAS7  PPEF1  PIN1  BAI2  KCNF1  COPS4  EHD3  TOMM70A AP3B2  VAMP2  SLC25A4  LARGE  LRPAP1  SERPINF1 IDH3G  FIBP   Down%in%disease   SNAP25   NPTX2  VAPB  RAD51C  NEFL  NEDD4L  PLD3  RUVBL2  STXBP1  THY1  TLN2  KIAA1045  CACNG3  PTPRN   EPHA4  CAP2  ST6GALNAC5 MET  GSE1297  TPI1  RGS7  BNIP3  SYP  GSE36980  C14orf132  GOT2  SNAP25  ATP1A3  GSE44772  MRPS11  GNG3  NEUROD6  ATP6V1G2  GSE5281  ATP5B  PTPRN2  MAGED1  C14orf2  SLC25A11  PPP1R11  SLC17A7  CACNG3  AP3B2 YWHAB ATP6V1E1 UQCRC1
Supplementary

Genes%upregulated%in%disease%in%multiple%gene%expression%datasets
Up#in#datasets: GSE1297  3  GSE15222  GSE36980  GSE44772   GSE1297  3  GSE15222  GSE36980  GSE5281   GSE1297  MAP4K4  KTN1  CASC3  GSE15222  EHD1  ZHX3  FYCO1  GSE44772  JARID2  NPAS3  SASH1  GSE5281  PCSK5  SLC12A7  VAT1  HIPK2  NAV2  TBL1X  ANP32B  PTBP1  PTMA  EIF5B  TFEB  MXI1  MAPKAPK2 RXRA  NOTCH1  ABCA1  CTBP2  RBBP6   GSE15222  ARHGEF10  GSE36980  COLEC12  GSE44772  H3F3A  GSE5281   GSE1297  3  GSE36980  GSE44772  GSE5281 
